A detailed history of Planning Capital Management Corp transactions in Organon & Co. stock. As of the latest transaction made, Planning Capital Management Corp holds 54 shares of OGN stock, worth $870. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54
Previous 54 -0.0%
Holding current value
$870
Previous $1.12 Million 7.51%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$17.45 - $21.96 $1,169 - $1,471
-67 Reduced 55.37%
54 $1.12 Million
Q1 2024

Apr 26, 2024

BUY
$13.78 - $18.8 $124 - $169
9 Added 8.04%
121 $2.28 Million
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $1,226 - $1,939
112 New
112 $1.62 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.1B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Planning Capital Management Corp Portfolio

Follow Planning Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Planning Capital Management Corp with notifications on news.